BRKR – Bruker Corporation
BRKR — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
10.37
Margin Of Safety %
13
Put/Call OI Ratio
0.7
EPS Next Q Diff
-0.14
EPS Last/This Y
2.27
EPS This/Next Y
0.3
Price
36.67
Target Price
47.47
Analyst Recom
2.06
Performance Q
-28.45
Upside
-109.0%
Beta
1.19
Ticker: BRKR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | BRKR | 37.2 | 0.49 | 2.18 | 13604 |
| 2026-03-10 | BRKR | 36.6 | 0.50 | 0.03 | 13646 |
| 2026-03-11 | BRKR | 36.82 | 0.50 | 1.00 | 13495 |
| 2026-03-12 | BRKR | 35.04 | 0.51 | 0.36 | 13508 |
| 2026-03-13 | BRKR | 35.05 | 0.51 | 0.37 | 13508 |
| 2026-03-17 | BRKR | 33.71 | 0.50 | 1.14 | 13601 |
| 2026-03-18 | BRKR | 34.04 | 0.50 | 4.45 | 13641 |
| 2026-03-19 | BRKR | 33.62 | 0.50 | 6.00 | 13660 |
| 2026-03-20 | BRKR | 33.33 | 0.48 | 2.41 | 13457 |
| 2026-03-23 | BRKR | 34.84 | 0.90 | 0.53 | 4314 |
| 2026-03-24 | BRKR | 35.79 | 0.83 | 0.22 | 4502 |
| 2026-03-25 | BRKR | 35.78 | 0.82 | 0.09 | 4555 |
| 2026-03-26 | BRKR | 35.3 | 0.77 | 0.13 | 4784 |
| 2026-03-27 | BRKR | 33.74 | 0.76 | 0.04 | 4799 |
| 2026-03-30 | BRKR | 34.3 | 0.76 | 0.14 | 4818 |
| 2026-03-31 | BRKR | 36.1 | 0.76 | 0.30 | 4839 |
| 2026-04-01 | BRKR | 36.07 | 0.71 | 0.00 | 5249 |
| 2026-04-02 | BRKR | 36.77 | 0.70 | 0.00 | 5255 |
| 2026-04-06 | BRKR | 36.76 | 0.70 | 0.87 | 5258 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | BRKR | 37.20 | -51.0 | 481.0 | 2.12 |
| 2026-03-10 | BRKR | 36.62 | -51.0 | 468.3 | 2.12 |
| 2026-03-11 | BRKR | 36.83 | -51.0 | 477.6 | 2.12 |
| 2026-03-12 | BRKR | 35.04 | -51.0 | 454.5 | 2.12 |
| 2026-03-13 | BRKR | 33.74 | -51.0 | 459.3 | 2.12 |
| 2026-03-17 | BRKR | 33.72 | -51.0 | 487.0 | 2.12 |
| 2026-03-18 | BRKR | 34.06 | -51.0 | 478.8 | 2.12 |
| 2026-03-19 | BRKR | 33.62 | -51.0 | 348.6 | 2.12 |
| 2026-03-20 | BRKR | 33.35 | -50.8 | 346.1 | 2.12 |
| 2026-03-23 | BRKR | 34.84 | -50.8 | 360.2 | 2.12 |
| 2026-03-24 | BRKR | 35.81 | -50.8 | 369.5 | 2.12 |
| 2026-03-25 | BRKR | 35.80 | -50.8 | 369.4 | 2.12 |
| 2026-03-26 | BRKR | 35.32 | -50.8 | 364.9 | 2.12 |
| 2026-03-27 | BRKR | 33.73 | -50.8 | 349.7 | 2.12 |
| 2026-03-30 | BRKR | 34.31 | -50.8 | 355.1 | 2.12 |
| 2026-03-31 | BRKR | 36.11 | -51.3 | 372.4 | 2.12 |
| 2026-04-01 | BRKR | 36.06 | -51.3 | 372.0 | 2.12 |
| 2026-04-02 | BRKR | 36.77 | -51.3 | 378.8 | 2.12 |
| 2026-04-06 | BRKR | 36.80 | -50.8 | 379.0 | 2.12 |
| 2026-04-07 | BRKR | 36.67 | -50.8 | 377.4 | 2.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | BRKR | -0.12 | 2.20 | 10.54 |
| 2026-03-10 | BRKR | -0.12 | 2.20 | 10.54 |
| 2026-03-11 | BRKR | -0.12 | 2.20 | 10.11 |
| 2026-03-12 | BRKR | -0.12 | 2.20 | 10.11 |
| 2026-03-13 | BRKR | -0.11 | 2.20 | 10.11 |
| 2026-03-17 | BRKR | -0.12 | 2.50 | 10.11 |
| 2026-03-18 | BRKR | -0.12 | 2.50 | 10.11 |
| 2026-03-19 | BRKR | -0.12 | 2.50 | 10.11 |
| 2026-03-20 | BRKR | -0.12 | 2.50 | 10.11 |
| 2026-03-23 | BRKR | -0.12 | 2.47 | 10.11 |
| 2026-03-24 | BRKR | -0.12 | 2.47 | 10.11 |
| 2026-03-25 | BRKR | -0.12 | 2.47 | 10.37 |
| 2026-03-26 | BRKR | -0.12 | 2.47 | 10.37 |
| 2026-03-27 | BRKR | -0.12 | 2.47 | 10.37 |
| 2026-03-30 | BRKR | -0.12 | 2.31 | 10.37 |
| 2026-03-31 | BRKR | -0.12 | 2.31 | 10.37 |
| 2026-04-01 | BRKR | -0.12 | 2.31 | 10.37 |
| 2026-04-02 | BRKR | -0.12 | 2.31 | 10.37 |
| 2026-04-06 | BRKR | -0.12 | 2.31 | 10.37 |
| 2026-04-07 | BRKR | -0.12 | 2.31 | 10.37 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.59
Avg. EPS Est. Current Quarter
0.23
Avg. EPS Est. Next Quarter
0.45
Insider Transactions
-0.12
Institutional Transactions
2.31
Beta
1.19
Average Sales Estimate Current Quarter
794
Average Sales Estimate Next Quarter
853
Fair Value
41.28
Quality Score
53
Growth Score
63
Sentiment Score
46
Actual DrawDown %
61.3
Max Drawdown 5-Year %
-68.7
Target Price
47.47
P/E
Forward P/E
15.12
PEG
1.02
P/S
1.62
P/B
2.27
P/Free Cash Flow
128.91
EPS
-0.15
Average EPS Est. Cur. Y
2.12
EPS Next Y. (Est.)
2.42
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-0.65
Relative Volume
0.61
Return on Equity vs Sector %
-28.4
Return on Equity vs Industry %
-12.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
377.4
◆
BRKR
Healthcare
$36.67
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
50.6
Range 1M
75.3%
Sup Dist
1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
15.6%
EPS NY
14.6%
52W%
28.9%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+32.3% upside
Upside
+32.3%
Quality
53
MoS
13%
Bruker CorporationSector: Healthcare
Industry: Medical Devices
Employees: 11085
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
BRKR
Latest News
—
Caricamento notizie per BRKR…
stock quote shares BRKR – Bruker Corporation Stock Price stock today
news today BRKR – Bruker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BRKR – Bruker Corporation yahoo finance google finance
stock history BRKR – Bruker Corporation invest stock market
stock prices BRKR premarket after hours
ticker BRKR fair value insiders trading